Cytokinetics prices 11,338,028-share follow-on offering at $71, raising $805 million

Cytokinetics, Incorporated

Cytokinetics, Incorporated

CYTK

0.00
  • Cytokinetics closed an underwritten public offering of 11,338,028 common shares at USD 71 per share.
  • Deal size reflects full exercise of underwriters’ option for 1,478,873 additional shares.
  • Gross proceeds totaled about USD 805 million, before underwriting discounts, commissions, and offering expenses.
  • All shares in offering were sold by Cytokinetics.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cytokinetics Incorporated published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605081051PRIMZONEFULLFEED9716512) on May 08, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.